Effect of vonoprazan, a potassium competitive acid blocker, in post endoscopic submucosal dissection ulcer healing

Effect of vonoprazan, a potassium competitive acid blocker, in post endoscopic submucosal dissection ulcer healing - Effect of vonoprazan, a potassium competitive acid blocker, in post endoscopic submucosal dissection ulcer healing

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022595

Enrollment

115

Registered

2016-06-10

Start date

2016-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer/gastric adenoma

Interventions

Vonoprazan administration(20mg, 8weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who have given written informed consent to this study, and age at the time of the agreement acquisition is 20 years or older.

Exclusion criteria

Exclusion criteria: 1) The patients on antithrombotic therapy. 2) The patients on dialysis. 3) The patients with a history of allergy to vonoprazan. 4) The patients on administration of atazanavir or rilpivirine. 5) Those who are considered to be inappropriate for this study by doctors.

Design outcomes

Primary

Measure	Time frame
Post ESD bleeding rate of the patient who ESD was perfomed.	—

Secondary

Measure	Time frame
Post ESD perforation rate of the patient who ESD was perfomed.	—

Countries

Japan

Contacts

Public ContactTaro Akashi

Nagasaki University Hospital Department of GASTROENTEROLOGY and HEPATOLOGY

fuk.naga.23@gmail.com095-819-7481

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026